Skip to content
Home/Companies/Biotech/Enterprise Therapeutics
ET

Enterprise Therapeutics

Biotech·United Kingdom·Active·2yr hold

Enterprise Therapeutics is a biotech company, headquartered in United Kingdom.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Enterprise Therapeutics?

Enterprise Therapeutics is currently owned by Panakes Partners SGR through Panakes Fund Purple (2021 vintage), since 2024.

Hand-verified · updated 2026-07-23

Panakes Partners SGR
Investor
Panakes Partners SGR
Panakes Fund Purple · 2021 · Life Sciences VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Panakes Fund Purple

Other portfolio companies in the same fund.

Deepull
Active
MedTechSpain· 2025
Endovascular Engineering
Active
MedTechUnited States· 2025
NanoPhoria
Active
BiotechItaly· 2025
Tensive
Active
MedTechItaly· 2025
CorFlow Therapeutics
Active
MedTechSwitzerland· 2024
DISCO Pharmaceuticals
Active
BiotechSwitzerland· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings